Seagen (Canada)

Seagen (Canada)

Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Seagen (Canada), Canada, covering academic research published from 2002 to 2024. Read More.


Open Access Percentage

77%


Total
Publications

87


Total Open
Publications

67


Total
Citations

6.4K


Open Access
Percentage

77%


Total
Publications

87


Total Open
Publications

67


Total
Citations

6.4K

Wikipedia

Website

download

Breakdown

27% 32% 18% 23%

Publisher Open

27%

Both

32%

Other Platform Open

18%

Closed

23%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01234567891011Total Publications
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

18%OA Journal

OA Journal 18%

9

Hybrid 17%

9

No Guarantees 65%

33

Other Platform Open

Domain 84%

37

Institution 23%

10

Other Internet 9%

4

Preprint 7%

3

Public 7%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
36
Europe PMC
Domain
24
DOI
Other Internet
4
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
3
Research Square
Preprint
3
Zenodo
Public
2
University of Michigan - Deep Blue
Institution
2
Harvard University - Digital Access to Scholarship at Harvard (DASH)
Institution
2
Augsburg University - OPUS - Augsburg University Publication Server
Institution
2
University of Toronto - TSpace
Institution
1
1 / 2

Data updated 7 April 2025

Share

Share

Share